Published by Global Banking & Finance Review®
Posted on February 5, 2025
3 min readLast updated: January 26, 2026
Add as preferred source on Google
The STOXX 600 index rose 0.36% as healthcare stocks like Novo Nordisk and GSK gained, offsetting declines in auto stocks.
By Nikhil Sharma and Johann M Cherian
(Reuters) - European shares ended Wednesday's choppy session higher, as a rise in healthcare companies GSK and Novo Nordisk following their upbeat quarterly results offset losses in carmaker stocks.
The pan-European STOXX 600 index reversed early losses and settled up 0.36%, with healthcare leading sectoral gains with a 2.1% jump.
Novo Nordisk rose 4.5% after the drugmaker posted a better-than-expected fourth-quarter profit of $4.4 billion as sales for its blockbuster drug Wegovy more than doubled. However, the largest European company by market capitalization forecast slower sales growth this year.
"There are also some concerns emerging about long-term tolerability. But there’s still a long way to run given the profound health economic impact this class of drug promises to deliver," said Derren Nathan, head of equity research at Hargreaves Lansdown.
GSK rose 7.6% after the British drugmaker launched a $2.5 billion share buyback plan, while also posting upbeat quarterly results and lifting its 2031 sales target.
Limiting gains on the STOXX index, automobile stocks fell 1.4%, bogged down by Renault's 2.6% drop, after a report said Japan's Nissan would call off merger talks with rival Honda.
Out of the 67 companies in the STOXX 600 that have reported fourth quarter earnings as of Tuesday, 53.7% exceeded analyst estimates, compared with 54% in a typical quarter, according to data compiled by LSEG.
European equities, along with their global peers, started the week on a sour note after U.S. President Donald Trump's tariff threats, but rebounded a day later when he agreed to pause levies on goods from Mexico and Canada and said he was open to negotiations.
Trump, however, followed through with tariffs on China, which retaliated in kind, although the fallout of that has been limited on global stocks.
On the European Central Bank monetary policy outlook, investors awaited the updated estimates for the so-called neutral rate due on Friday. The neutral rate is the interest rate level with full employment and stable inflation.
Among others, Santander soared 8.2% after the lender beat fourth-quarter profit estimates and announced a share buyback plan worth 10 billion euros ($10.39 billion).
Vestas jumped to the top of the STOXX index, up 8.2% after the world's biggest wind turbine maker, announced a share buyback and reported upbeat fourth-quarter results.
The Danish stock index surged 2.9%, logging its steepest one-day jump in more than one week.
Munters slid more than 10.2% to the bottom of the STOXX after the Swedish maker of air treatment solutions reported what analysts say were "mixed" fourth-quarter results.
(Reporting by Nikhil Sharma and Johann M Cherian; Editing by Rashmi Aich, Savio D'Souza and Alex Richardson)
The rise in European stocks was primarily driven by gains in healthcare companies like GSK and Novo Nordisk, which reported upbeat quarterly results.
Automobile stocks fell by 1.4%, with Renault experiencing a 2.6% drop, largely due to Nissan calling off merger talks with Honda.
The pan-European STOXX 600 index ended the session up 0.36%, reversing early losses with healthcare leading the sectoral gains.
Investors are closely watching the updated estimates for the European Central Bank's neutral rate, which is the interest rate level associated with full employment.
Both GSK and Santander announced significant share buyback plans, with GSK launching a $2.5 billion plan and Santander announcing a €10 billion plan.
Explore more articles in the Finance category
